Morpholino

MO2-fhl1a

ID
ZDB-MRPHLNO-140707-3
Name
MO2-fhl1a
Previous Names
  • fhlA -MO2 (1)
Target
Sequence
5' - GACCTGAGTGCCTGTAGTAGCTCAT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-fhl1a
No data available
Phenotype
Phenotype resulting from MO2-fhl1a
Phenotype of all Fish created by or utilizing MO2-fhl1a
Phenotype Fish Conditions Figures
whole organism pax7a expression decreased amount, abnormal AB + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3 from Chen et al., 2018
somite decreased size, abnormal AB + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 1 from Chen et al., 2018
whole organism mylk2 expression decreased amount, abnormal AB + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3 from Chen et al., 2018
somite mef2ca expression decreased amount, abnormal AB + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3 from Chen et al., 2018
somite shape, abnormal AB + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 1 from Chen et al., 2018
somite myod1 expression decreased amount, abnormal AB + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 2Fig. 4 from Chen et al., 2018
somite morphology, abnormal AB + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 1 from Chen et al., 2018
skeletal muscle ab-mf20 labeling decreased distribution, abnormal AB + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 2 from Chen et al., 2018
skeletal muscle satellite cell decreased amount, abnormal AB + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3 from Chen et al., 2018
whole organism pax7b expression decreased amount, abnormal AB + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3 from Chen et al., 2018
trunk decreased length, abnormal WT + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 2 from Xie et al., 2013
cardiac ventricle has extra parts of type cell, abnormal WT + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 5Fig. S2 from Xie et al., 2013
whole organism curved, abnormal WT + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 2 from Xie et al., 2013
pigmentation decreased process quality, abnormal WT + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 2 from Xie et al., 2013
cardiac ventricle increased size, abnormal WT + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3Fig. 6 from Xie et al., 2013
heart contraction process quality, abnormal WT + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 4 from Xie et al., 2013
atrium increased size, abnormal WT + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3Fig. 6 from Xie et al., 2013
atrium has extra parts of type cell, abnormal WT + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 5Fig. S2 from Xie et al., 2013
whole organism curved, abnormal WT + MO1-fhl1a + MO2-fhl1a + MO4-tp53 standard conditions Fig. 2 from Xie et al., 2013
pigmentation decreased process quality, abnormal WT + MO1-fhl1a + MO2-fhl1a + MO4-tp53 standard conditions Fig. 2 from Xie et al., 2013
trunk decreased length, abnormal WT + MO1-fhl1a + MO2-fhl1a + MO4-tp53 standard conditions Fig. 2 from Xie et al., 2013
trunk decreased length, abnormal WT + MO2-fhl1a standard conditions Fig. 2 from Xie et al., 2013
pigmentation decreased process quality, abnormal WT + MO2-fhl1a standard conditions Fig. 2 from Xie et al., 2013
whole organism curved, abnormal WT + MO2-fhl1a standard conditions Fig. 2 from Xie et al., 2013
cardiac ventricle increased size, abnormal hsc4Tg + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3 from Xie et al., 2013
atrium increased size, abnormal hsc4Tg + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3 from Xie et al., 2013
atrium increased size, abnormal pku3Et + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3 from Xie et al., 2013
cardiac ventricle increased size, abnormal pku3Et + MO1-fhl1a + MO2-fhl1a standard conditions Fig. 3 from Xie et al., 2013
Citations